Literature DB >> 25352025

Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.

Wei Jiang1, Feng Yao, Jing He, Bihong Lv, Wentao Fang, Weidong Zhu, Guangming He, Jianzhong Chen, Jianming He.   

Abstract

VGLL4, a member of the Vestigial-like (VGLL) proteins, has been reported to be dysregulated in several cancer types. However, its function in esophageal squamous cell carcinoma (ESCC) remains poorly understood. Here, it was found that the expression level of VGLL4 was decreased in ESCC tissues. Moreover, forced expression of VGLL4 in ESCC cells inhibited cell growth and migration, while knockdown of VGLL4 expression promoted the tumorigenecity of ESCC cells. Mechanistically, VGLL4 regulated the growth and motility of ESCC cells through downregulating the expression of connective tissue growth factor (CTGF), a known oncogene in the progression of ESCC. Taken together, our study suggested that downregulation of VGLL4 was very important in the progression of ESCC, and restoring the function of VGLL4 might be a promising therapeutic strategy for ESCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25352025     DOI: 10.1007/s13277-014-2701-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes.

Authors:  Hsiao-Huei Chen; Steven J Mullett; Alexandre F R Stewart
Journal:  J Biol Chem       Date:  2004-05-12       Impact factor: 5.157

2.  A novel inhibitor of apoptosis protein (IAP)-interacting protein, Vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration.

Authors:  Hyung-Seung Jin; Hyung-Sun Park; Jun-Ha Shin; Dong-Hwan Kim; Sung-Hun Jun; Chang-Jun Lee; Tae H Lee
Journal:  Biochem Biophys Res Commun       Date:  2011-08-04       Impact factor: 3.575

3.  YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.

Authors:  Zofia Hélias-Rodzewicz; Gaëlle Pérot; Frédéric Chibon; Céline Ferreira; Pauline Lagarde; Philippe Terrier; Jean-Michel Coindre; Alain Aurias
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

4.  Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Authors:  Jian-Jun Xie; Li-Yan Xu; Jian-Yi Wu; Zhong-Ying Shen; Qing Zhao; Ze-Peng Du; Zhuo Lv; Wei Gu; Feng Pan; Xiu-E Xu; Dong Xie; En-Min Li
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

5.  Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.

Authors:  Yue-Zhen Deng; Ping-Ping Chen; Yan Wang; Dong Yin; H Phillip Koeffler; Baojie Li; Xiang-Jun Tong; Dong Xie
Journal:  J Biol Chem       Date:  2007-10-21       Impact factor: 5.157

6.  Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada; Yoshihiro Nabeya; Shin-ichi Okazumi; Hisahiro Matsubara; Tooru Shiratori; Yoshio Gunji; Susumu Kobayashi; Hideki Hayashi; Takenori Ochiai
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

7.  Molecular biology of esophageal cancer.

Authors:  R Metzger; P M Schneider; U Warnecke-Eberz; J Brabender; A H Hölscher
Journal:  Onkologie       Date:  2004-04

8.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

9.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

Review 10.  Emerging roles of TEAD transcription factors and its coactivators in cancers.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

View more
  13 in total

1.  Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.

Authors:  Ailing Wu; Qingzhe Wu; Yujie Deng; Yuning Liu; Jinqiu Lu; Liansheng Liu; Xiaoling Li; Cheng Liao; Bin Zhao; Hai Song
Journal:  EMBO J       Date:  2018-11-05       Impact factor: 11.598

2.  Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4 protein.

Authors:  Encheng Zhang; Bing Shen; Xingyu Mu; Yan Qin; Fang Zhang; Yong Liu; Jiantao Xiao; Pingzhao Zhang; Chenji Wang; Mingyue Tan; Yu Fan
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

3.  miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.

Authors:  Nan Li; Nanrong Yu; Jia Wang; Haofeng Xi; Weiqun Lu; Houwei Xu; Min Deng; Guopei Zheng; Haiying Liu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 4.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

5.  Integration of single nucleotide variants and whole-genome DNA methylation profiles for classification of rheumatoid arthritis cases from controls.

Authors:  Mahmoud Amiri Roudbar; Mohammad Reza Mohammadabadi; Ahmad Ayatollahi Mehrgardi; Rostam Abdollahi-Arpanahi; Mehdi Momen; Gota Morota; Fernando Brito Lopes; Daniel Gianola; Guilherme J M Rosa
Journal:  Heredity (Edinb)       Date:  2020-03-03       Impact factor: 3.821

Review 6.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

7.  VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.

Authors:  McKayla Mickle; Gautam Adhikary; Suruchi Shrestha; Wen Xu; Richard L Eckert
Journal:  Mol Carcinog       Date:  2021-05-18       Impact factor: 5.139

8.  VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.

Authors:  Yinglong Zhang; He Shen; Henry G Withers; Nuo Yang; Kayla E Denson; Ashley L Mussell; Alexander Truskinovsky; Qingyu Fan; Irwin H Gelman; Costa Frangou; Jianmin Zhang
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

9.  Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.

Authors:  Manu Shivakumar; Younghee Lee; Lisa Bang; Tullika Garg; Kyung-Ah Sohn; Dokyoon Kim
Journal:  BMC Med Genomics       Date:  2017-05-24       Impact factor: 3.063

10.  Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells.

Authors:  Jian Han; Jia Li; Jolene Caifeng Ho; Grace Sushin Chia; Hiroyuki Kato; Sudhakar Jha; Henry Yang; Lorenz Poellinger; Kian Leong Lee
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.